On the one hand, it has been claimed that detection of IgA–aPL is significantly correlated with thrombosis and obstetric complications (10), and the presence of IgA–aβ2GPI in people with no history of thrombosis events is an independent risk factor for the development of these types of events (11–14). The gene discussed is CD79A; the disease is deep vein thrombosis.